Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$374M |
| 2 |
AT&T
T
|
+$293M |
| 3 |
NVIDIA
NVDA
|
+$291M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$283M |
| 5 |
Williams Companies
WMB
|
+$274M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.09B |
| 2 |
Lam Research
LRCX
|
+$351M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$330M |
| 4 |
Apple
AAPL
|
+$328M |
| 5 |
Boeing
BA
|
+$292M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 52.95% |
| 2 | Technology | 8.38% |
| 3 | Healthcare | 7.98% |
| 4 | Financials | 6.14% |
| 5 | Consumer Discretionary | 5.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2826
PUT
Arthur J. Gallagher & Co
AJG
$68.6B
| $3.69M | ﹤0.01% |
19,300
-7,600
| -28% | -$1.44M |
|
2827
PUT
Teva Pharmaceuticals
TEVA
$42.5B
| $3.69M | ﹤0.01% |
417,200
+119,100
| +40% | +$1.18M |
|
|
FITB
2828
CALL
Fifth Third Bancorp
FITB
$49.5B
| $3.69M | ﹤0.01% |
138,500
-11,300
| -8% | -$375K |
|
2829
CALL
Ares Capital
ARCC
$14.3B
| $3.67M | ﹤0.01% |
+201,000
| New | +$3.8M |
|
2830
Unitil
UTL
$968M
| $3.67M | ﹤0.01% |
+64,355
| New | +$3.44M |
|
2831
CALL
Pinterest
PINS
$13.1B
| $3.67M | ﹤0.01% |
134,500
-183,300
| -58% | -$4.75M |
|
2832
PDS Biotechnology
PDSB
$11.8M
| $3.67M | ﹤0.01% |
596,272
+144,936
| +32% | +$1.19M |
|
2833
Vanguard Total World Stock ETF
VT
$81.2B
| $3.67M | ﹤0.01% |
+39,821
| New | +$3.61M |
|
2834
PUT
Ralph Lauren
RL
$21.1B
| $3.66M | ﹤0.01% |
31,400
+21,800
| +227% | +$2.57M |
|
|
CFFS
2835
DELISTED
CF Acquisition Corp. VII Class A Common Stock
CFFS
| $3.65M | ﹤0.01% |
353,000
+500
| +0.1% | +$5.12K |
|
2836
CALL
Spotify
SPOT
$113B
| $3.65M | ﹤0.01% |
27,300
+1,500
| +6% | +$172K |
|
2837
CALL
Raymond James Financial
RJF
$34.5B
| $3.64M | ﹤0.01% |
+39,000
| New | +$4.13M |
|
2838
CALL
Stellantis
STLA
$20.4B
| $3.64M | ﹤0.01% |
+200,000
| New | +$3.34M |
|
|
CTIC
2839
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $3.64M | ﹤0.01% |
866,152
-3,896,617
| -82% | -$20.2M |
|
2840
CALL
Tenet Healthcare
THC
$21.5B
| $3.64M | ﹤0.01% |
61,200
-83,400
| -58% | -$4.64M |
|
2841
American Vanguard Corp
AVD
$64.6M
| $3.63M | ﹤0.01% |
166,149
+65,423
| +65% | +$1.41M |
|
2842
Xponential Fitness
XPOF
$229M
| $3.63M | ﹤0.01% |
119,562
-321,275
| -73% | -$8.5M |
|
2843
PUT
Take-Two Interactive
TTWO
$44B
| $3.63M | ﹤0.01% |
30,400
-6,300
| -17% | -$703K |
|
|
RVNC
2844
DELISTED
Revance Therapeutics, Inc.
RVNC
| $3.63M | ﹤0.01% |
112,567
-385,262
| -77% | -$12M |
|
2845
PUT
Synchrony
SYF
$25.4B
| $3.62M | ﹤0.01% |
124,500
+79,400
| +176% | +$2.67M |
|
|
ARTE
2846
DELISTED
Artemis Strategic Investment Corporation Class A Common Stock
ARTE
| $3.62M | ﹤0.01% |
350,000
-30,422
| -8% | -$313K |
|
2847
Ooma
OOMA
$629M
| $3.62M | ﹤0.01% |
289,178
+122,251
| +73% | +$1.64M |
|
2848
CALL
Welltower
WELL
$172B
| $3.61M | ﹤0.01% |
50,400
+31,800
| +171% | +$2.31M |
|
2849
Jakks Pacific
JAKK
$291M
| $3.59M | ﹤0.01% |
207,765
+44,831
| +28% | +$840K |
|
2850
Dover
DOV
$26.8B
| $3.59M | ﹤0.01% |
23,638
-496,750
| -95% | -$72.9M |
|
Similar funds
Israel Englander's Q1 2023 Portfolio in Review
As of Q1 2023, Israel Englander held 7,511 positions worth $174B, down 3.5% from $181B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Israel Englander withdrew a net $7.42B in Q1 2023, closing 1,206 positions and reducing 2,570 holdings. Its most notable exit was Apollo Global Management, an estimated $112M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 53% of assets, up from 53% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Israel Englander opened a new position in Warner Bros worth $96.9M.
- Israel Englander's largest Q1 2023 buy was Warner Bros: 6,417,147 shares worth $96.9M.
- Israel Englander added most to Linde in Q1 2023, an estimated $374M increase.
- Israel Englander's biggest Q1 2023 reduction was Invesco QQQ Trust, cutting an estimated $1.09B.
- Israel Englander fully exited Apollo Global Management in Q1 2023, selling an estimated $112M.
- Israel Englander's ten largest holdings make up 25% of its $174B portfolio in Q1 2023.
- Israel Englander opened 987 new positions and closed 1,206 in Q1 2023.
- Israel Englander's portfolio value fell 3.5% quarter-over-quarter to $174B.
Based on Millennium Management's 13F filing for Q1 2023, filed 15 May 2023.